I agree with you, some people trying to hype the PPS overnight, yes, OTIKO is making some good moves but Viaderma is really VERY FAR AWAY to be a disruptor, specially in the hair loss industry, very difficult field to triumph
BULLSHIT! Your post makes zero sense, as the VDRM delivery system is shaking up markets for many products, with many more to come! NO ONE IS CLAIMING VDRM PRODUCTS WILL GAIN 100% OF ANY MARKET AND IT DOES NOT NEED TO IN ORDER TO BE DISRUPTIVE!
This isn't just about Nupelo. There great value is in the transdermal delivery system, which is UNLIKE anything else available in the market and 10x more effective than all other market products.
They can create their own best-in-class products or work with industry leaders who can white label VDRMs solutions through licensing agreements. Multiple revenue streams from multiple business lines.